by employing biotinylated heparin as labeled ligand to visualize and quantify heparin binding , hapten inhibition in a solid-phase assay reveals that except for heparin no other vertebrate glycosaminoglycan but the sulfated fucan fucoidan can effectively reduce the ca2+-independent ligand binding .
C0019134
heparin
C0017973
glycosaminoglycan